Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...

Should employers, patients or insurers cover the $411 billion annual cost for GLP-1 drugs? U.S. healthcare industry grapples with this question as demand grows.

New research from The George Institute of Global Health shows that a popular class of obesity and type 2 diabetes drugs can ...

Whether this proposed rule actually has any impact remains to be seen, especially with a new administration led by Donald ...

About 7.4 million Americans with obesity could have insurance coverage for drugs like Wegovy if the Trump administration ...

The stock is now up more than 60% year to date, as of this writing. The question for investors is, can the momentum in the ...

If you’re taking a GLP-1 medication, some foods should be avoided — including a traditional favorite There are a few foods ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid ...

Ben McPoland reveals one top-notch growth stock down 29% that he plans to stuff into his portfolio in time for Christmas ...

Embecta announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan.